KLK3 and prostate carcinoma: The investigation revealed that using the SFN extract did not result in significant PSA declines in most of the patients with recurrent prostate cancer. Despite this, the treatment was found to be safe and had some positive effects on PSADT modulation. However, there is still a need for further investigation